Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N1087 (Oral Minoxidil) in Male Androgenetic Alopecia
NCT07529977Phase 3Not yet recruiting
- Sponsor
- Eurofarma
- Start
- Jan 2027
- Primary completion
- Oct 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of N1087 in androgenetic alopecia (AGA), sponsored by Eurofarma. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
N1087
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07529977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07529977.